Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 25, 18:09 PM 2012  
FNMFO KDDIF 096770 AMKBF CTGBZ AU 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for CHBT

ChinaBiotics performance

    
    

ChinaBiotics Inc.

 Stock@American Stock Exchange 
United States
    
Use ChinaBiotics Inc. performance together with your portfolio to protect against small markets fluctuations and to determine Stock optimization strategy that fits your criteria.
    
    
       
Investment horizon: 
30 Days (Login to change)
       

Relative Risk vs. Return Landscape

If you would invest 143.00 in ChinaBiotics Inc. on April 25, 2012 and sell it today you would lose (64.00) from holding ChinaBiotics Inc. or give up 44.76% of portfolio value over 30 days. ChinaBiotics Inc. is currenly does not generate positive expected returns and assumes 10.85% risk (volatility on return distribution) over the 30 days horizon. In different words, most equities are less risky than ChinaBiotics Inc. and most traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
Daily Expected Return (%)
Risk [Daily Volatility] (%)
Given investment horizon of 30 days, ChinaBiotics Inc. is expected to under-perform the market. In addition to that, the company is 14.28 times more volatile than its market benchmark. It trades about -0.16 of its total potential returns per unit of risk. The NYSE is currently generating roughly -0.39 per unit of volatility.

ChinaBiotics Operating Margin

Based on recorded statements ChinaBiotics Inc. has Operating Margin of 0.0%. This indicator is about the same for null average (which is currently at 0.0) sector, and about the same as operatingMargin (which currently averages 0.0) industry, This indicator is about the same for all stocks average (which is currently at 0.0).
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.

Discuss ChinaBiotics performance

       
       
    
ChinaBiotics
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days ChinaBiotics Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    

1 Month Effecincy (a.k Sharpe Ratio) ...

-0.16
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsCHBT

Estimated Market Risk

 10.85
  actual daily
 
 4 %
of total potential
 
Market Risk score

Expected Return

 -1.69
  actual daily
 
 1 %
of total potential
 
Expected Return score

Risk-Adjusted Return

 -0.16
  actual daily
 
 1 %
of total potential
 
Risk-Adjusted Return score
Based on monthly moving average ChinaBiotics is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ChinaBiotics by adding it to a well-diversified portfolio.
    
Follow ChinaBiotics Performance with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add ChinaBiotics to your reader
 
Get social with ChinaBiotics Performance
 ChinaBiotics Performance 
Share Toggle social options for ChinaBiotics Performance
    



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting